Alfried Krupp Zentrum fuer Medizin und Rehabilitation gGmbH
- Address
- Alfried-Krupp-Str. 21, Ruettenscheid, 45131 Essen, Germany
Alfried Krupp Zentrum für Medizin und Rehabilitation gGmbH
The Alfried Krupp Zentrum für Medizin und Rehabilitation gGmbH is a specialized medical institution engaged in advanced research focused on acute cerebrovascular disorders and innovative treatment strategies. The center demonstrates particular expertise in developing and evaluating novel therapeutic approaches for time-critical neurological emergencies.
- Acute ischemic stroke intervention and management
- Endovascular recanalization techniques and optimization
- Thrombolytic therapy refinement and supplementary applications
The institution is actively investigating cutting-edge treatment protocols, including the LOCAL trial, which examines whether supplementary intra-arterial thrombolysis with Tenecteplase following successful endovascular recanalization can enhance clinical outcomes in anterior circulation ischemic stroke patients. This research aims to optimize functional recovery, specifically targeting excellent clinical outcomes measured by modified Rankin Scale (mRS) scores, representing a commitment to advancing stroke care through evidence-based therapeutic innovations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Alfried Krupp Zentrum fuer Medizin und Rehabilitation gGmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack | Janssen Cilag International | Phase III | Not Recruiting | Aug 2023 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2023-08-04 | 2023-08-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.